The descriptive roles played by PD-L1 in cancer and its characterization will provide opportunities to develop new immunotherapies that change the roles of PD-L1 as an immune checkpoint modulator and its intrinsic tumor supporting functions. The gene discussed is CD274; the disease is neoplasm.